鵬程亞洲(00936.HK)失去對附屬廣東大合之控制
鵬程亞洲(00936.HK)公布,有關於附屬公司廣東大合少數股東提起的一項法院訴訟以及出售佳誠51%股權的事宜,公司管理層多次向廣東大合作出口頭及書面要求並曾親自前赴廣東大合的辦公室,但自2019年12月28日起至今公司人員仍被拒絕進入廣東大合之辦公室及種植場。公司一直未能取得廣東大合自去年12月1日以後的完整賬目及記錄連同證明文件。董事會認為集團已失去對廣東大合之控制。經諮詢公司核數師後,公司認為廣東大合之財務業績將不再於集團之業績綜合入賬,即時生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.